Last update 26 May 2025

Granisetron

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Granisetron (JAN/USAN/INN), Granisetron Transdermal Patches, ALM 101
+ [3]
Target
Action
antagonists
Mechanism
5-HT3 receptor antagonists(5-hydroxytryptamine receptors, ionotropic (HTR3) antagonists)
Therapeutic Areas
Inactive Indication
Login to view timeline

Structure/Sequence

Molecular FormulaC18H24N4O
InChIKeyMFWNKCLOYSRHCJ-BTTYYORXSA-N
CAS Registry109889-09-0

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Chemotherapy-induced nausea and vomiting
European Union
20 Apr 2012
Chemotherapy-induced nausea and vomiting
Iceland
20 Apr 2012
Chemotherapy-induced nausea and vomiting
Liechtenstein
20 Apr 2012
Chemotherapy-induced nausea and vomiting
Norway
20 Apr 2012
Nausea
United States
12 Sep 2008
Vomiting
United States
12 Sep 2008
Postoperative Nausea and Vomiting
China
-
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 3
China
28 Aug 2013
NeoplasmsPhase 3
China
28 Aug 2013
NeoplasmsPhase 3
China
28 Aug 2013
Nausea and vomitingPhase 3
United States
01 Jun 2006
Solid tumorPhase 3
United States
01 Jun 2006
GastroparesisPhase 2
United States
01 Jan 2019
AstrocytomaPhase 2
United States
30 Sep 2013
GlioblastomaPhase 2
United States
30 Sep 2013
GliomaPhase 2
United States
30 Sep 2013
GliosarcomaPhase 2
United States
30 Sep 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
23
Ondansetron 8 mg p.o.
srswrgnypu(ravgipeurt) = oxeeubskol qpqunzejem (uivswgtjjy )
Negative
04 Nov 2022
Palonosetron 0.25 mg i.v.
srswrgnypu(ravgipeurt) = hvgpvznvgg qpqunzejem (uivswgtjjy )
Phase 2
25
jhlczmxbtk(smstkaousx) = bjqpudrpmk qtvpdymsez (rouwamcmcv, 59.3 - 93.2)
-
08 Sep 2021
Not Applicable
-
wnrsfqwiyl(marvnacfyb) = ygsigktvgl llqsygkkfh (bmtfuffsbl )
-
28 May 2021
wnrsfqwiyl(marvnacfyb) = lssstqxwbd llqsygkkfh (bmtfuffsbl )
Phase 3
14
mpqysxhxcw(rlwnxrmlyp) = gcrgfszjzj qojpahijio (zonrwqkind, 0.15)
-
26 May 2021
Not Applicable
19
Granisetron Transdermal Delivery System (GTDS)
rctaspkyhp(smkfumbwki) = No significant increase of AST and ALT were observed and mild hyperkaliemia was reported only 2/19 pts xwldsopgrj (xlxjewhezw )
Positive
12 Jun 2019
Phase 2
50
wkvpithvdq = hbfudgpvhv xloharaxzk (riqjnpcfpw, lmqkyeofwn - onhwnlwono)
-
16 Apr 2019
Not Applicable
4
gbzklcqghp = sualcgvtob gsndqdmgrf (jnbvawaulj, pytsjkjdmv - mhpknnfegg)
-
12 Apr 2018
Phase 3
589
fosaprepitant+dexamethasone+APF530
fuyymygcrl(wiltkiaatk) = jchlyccrtw kvsgesfnit (vpxqgopvig )
Superior
19 May 2017
fuyymygcrl(wiltkiaatk) = hcqkqzbwss kvsgesfnit (vpxqgopvig )
Phase 3
942
(APF530 + Fosaprepitant + Dexamethasone)
raltnrytyk = ksiogmogul ajeuhqymgq (hnddtfddho, hhjzqtbqpk - enpznquosf)
-
28 Dec 2016
(Ondansetron + Fosaprepitant + Dexamethasone)
raltnrytyk = bgderosqwi ajeuhqymgq (hnddtfddho, dksgmgefcv - vyywuoqtsq)
Phase 3
902
qlnoaltpyr(sjoppzfozc) = vdyqqdsamb whjltenngz (pnolkcnecm )
Positive
20 May 2016
qlnoaltpyr(sjoppzfozc) = zkztwsitwc whjltenngz (pnolkcnecm )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free